Patient-Reported Outcomes Favor Concizumab Prophylaxis in Hemophilia A or B - AJMC.com Managed Markets Network
[unable to retrieve full-text content]
Patient-Reported Outcomes Favor Concizumab Prophylaxis in Hemophilia A or B AJMC.com Managed Markets Network
Comments
Post a Comment